Enfusion, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Non-cash operating lease expense
Non-cash lease expense
Depreciation and amortization
Provision for credit losses
Amortization of debt-related costs
Stock-based compensation expense
Change in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Accounts payable
Accrued compensation
Accrued expenses and other liabilities
Lease liabilities
Other non-current liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Capitalization of software development costs
Net cash used in investing activities
Cash flows from financing activities:
Distributions to non-controlling interests
Settlement of tax receivable acquired in reorganization transactions
Issuance of Class A common stock, net of issuance costs
Payment of withholding taxes on stock-based compensation
Repayment of term loan
Payment of member distributions
Purchases of common units from Pre-IPO common unit holders
Payment of debt issuance and debt facility costs
Issuance of Class A common stock in the IPO, net of issuance costs
Other financing activities
Net cash used in financing activities

Effect of exchange rate changes on cash
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of cash flow information:
Income taxes paid in cash
Interest paid in cash

Supplemental disclosure of non-cash activities:
Right-of-use assets obtained in exchange for lease liabilities
Capitalized stock-based compensation expense
Accrued property, equipment, and software, net
Effect of the Reorganization Transactions
IPO costs included in accrued expenses and other liabilities
Other

Comments